HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

FE 201874

a V(1A) vasopressin receptor agonist; structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Polycyclic Compounds: 6
- Macrocyclic Compounds: 15
  - Cyclic Peptides: 530
    - FE 201874: 1
Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Cyclic Peptides: 530
    - FE 201874: 1

Experts

1.	Desarménien, Michel G: 1 article (09/2013)
2.	Galibert, Evelyne: 1 article (09/2013)
3.	Guillon, Gilles: 1 article (09/2013)
4.	Haddou, Dominique: 1 article (09/2013)
5.	Marir, Rafik: 1 article (09/2013)
6.	Meraihi, Zahia: 1 article (09/2013)
7.	Mion, Julie: 1 article (09/2013)
8.	Virsolvy, Anne: 1 article (09/2013)
9.	Wisniewski, Kazimierz: 1 article (09/2013)

Related Diseases

1.	Septic Shock (Toxic Shock Syndrome) 09/01/2013 - "Hence, FE 201874 may have potential as a treatment for the vasodilator-induced hypotension occurring in conditions such as septic shock and could be the most suitable compound for discriminating between the behavioural effects of arginine vasopressin and oxytocin."

Related Drugs and Biologics

1.	Vasodilator Agents (Vasodilators)
2.	Oxytocin (Pitocin)
3.	Arginine Vasopressin (Argipressin)

Related Therapies and Procedures

1.	Controlled Hypotension